ASCENTAGE PHARMA GR-ADR (AAPG) Stock Income Statement
USA - NASDAQ:AAPG - ADR
39.78 USD
+0.2 (+0.51%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 390.60M | 980.65M | 221.98M | 209.71M | 27.91M | |||
| Minority Interest Expense | 128.00K | 247.00K | 75.00K | N/A | N/A | |||
| Cost Of Goods | 35.68M | 29.09M | 30.54M | 22.00M | 3.33M | |||
| Gross Profit | 354.93M | 951.57M | 191.44M | 187.71M | 24.58M | |||
| Operating Expenses | 1.48B | 1.33B | 1.07B | 1.04B | 917.83M | |||
| Research and Development | 1.00B | 913.81M | 706.97M | 743.10M | 766.49M | |||
| Selling, General, and Administrative Expenses | 393.31M | 331.77M | 376.46M | 328.02M | 191.26M | |||
| Operating Income | -1.12B | -374.17M | -874.04M | -852.93M | -893.25M | |||
| Interest Income/Expense | -22.02M | -21.03M | -58.83M | -36.30M | 61.00M | |||
| Non Recurring Items | N/A | -50.00K | 4.00K | 2.07M | N/A | |||
| Income Before Taxes | -1.14B | -395.25M | -932.86M | -887.17M | -832.25M | |||
| Income Tax | 15.87M | 10.43M | -7.15M | -4.25M | -49.83M | |||
| Net Income | -1.16B | -405.43M | -925.64M | -882.92M | -782.42M | |||
| EBITDA | N/A | -281.00M | -796.73M | -791.46M | -864.92M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -13.04 | -4.93 | -12.05 | -12.30 | -11.29 | |||
| Statistics | ||||||||
| Gross Profit Margin | 90.87% | 97.03% | 86.24% | 89.51% | 88.08% | |||
| Profit Margin | -296.77% | -41.34% | -416.98% | -421.02% | -2803.38% | |||
| Operating Profit Margin | -287.10% | -38.16% | -393.74% | -406.72% | -3200.45% | |||
All data in CNY